Expression of PD-1 defines a reversible defect of CMV-specific CD4 T cells that are associated with viremia, and blocking PD-1 signaling may provide a potential target for enhancing the function of exhausted T cells in chronic CMV infection. This evidence concerns the gene CD4 and cytomegalovirus infection.